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INTRODUCTION
The da Vinci Robotic Surgical System (Intuitive Surgical, Moun-
tain View, CA, USA) was initially introduced for cardiac sur-
gery in 1999, and it has been widely adapted for urologic, gy-
necologic, general, thoracic, and head and neck surgeries.1-4 
According to official statistics from Intuitive Surgical, approxi-
mately 2 million procedures were performed in 2013.5 Al-
though long-term oncologic outcomes are generally lacking and 
robotic surgeries are more expensive than other surgeries, ro-
botic technology is widely used in oncologic surgery, with 
demonstrated short-term advantages.4 Robotic surgery has 
overcome many limitations, including setup costs and surgical 
training. The tendency to shift from performing open surgery 
and laparoscopic surgery to robotic surgery seems to be inevita-
ble worldwide. 
Several studies have reported the efficacy and safety of robot-
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ic surgeries for various diseases, which have outcomes compa-
rable to those of conventional or laparoscopic surgeries.2,3,6-15 
However, to the best of our knowledge, no study has reported 
a comprehensive analysis based on the experience of multiple 
departments at a single institute. Since 2005, the Severance 
Hospital, Yonsei University Health System (Seoul, Korea) has 
been one of the largest centers in Asia that has adopted robot-
ics in the surgical field,9 and several reports on this have been 
published.2,3,6-15 
This work reviewed the annual trends of various robotic 
surgeries performed in multiple departments and analyzed 
the efficacy and safety of robotic surgeries, including surgical 
incidence, outcomes, morbidity, mortality, and mechanical fail-
ures, at a single institute. 
MATERIALS AND METHODS
Ethical considerations
The study was performed in agreement with the applicable 
laws and regulations, good clinical practices, and ethical prin-
ciples described in the Declaration of Helsinki. The Institu-
tional Review Board of Severance Hospital approved the study 
protocol (approval no. 1-2014-0023).
Data collection
All medical records of patients who underwent robotic surger-
ies between 2005 and 2013 at Severance Hospital, Yonsei Uni-
versity Health System were searched for and reviewed. De-
tailed statistical data regarding the patients and surgeries were 
provided by the Robot and Minimal Invasive Surgery Center 
of Severance Hospital. All surgeries were performed accord-
ing to the standard protocol of robotic surgeries provided by 
each department of our institute. Final analyses were per-
formed after manual sorting of all records and confirmation 
of consistency of the lists of patients from the Robot and Mini-
mal Invasive Surgery Center and the patient cohort from the 
electronic medical recording system of Severance Hospital. 
Comparative data regarding cases in Korea and the rest of 
the world were obtained from the database of the Ministry of 
Health and Welfare, Republic of Korea and from Intuitive Sur-
gical. Demographical data were obtained from the official re-
cords of the Statistics Korea in 2014.
Statistical analysis
All robotics procedures were classified into groups by year ac-
cording to diagnosis, department, organ, and surgeon. Subse-
quently, statistical analyses and comparisons were performed 
for the procedures at Severance Hospital, other domestic pro-
cedures, and robotic procedures elsewhere worldwide. To 
evaluate the reliability of the robotic system during various 
surgical procedures, additional analysis was performed re-
garding the incidence and type of perioperative malfunctions, 
failure of the da Vinci Surgical System (Intuitive Surgical) dur-
ing procedures, and their consequences. Mortality related to 
robotic surgery was also reported according to the year of oc-
currence.
RESULTS
Introduction and use of the da Vinci Surgical System 
at Severance Hospital 
Our institute initially introduced one standard da Vinci Surgi-
cal System (Intuitive Surgical) in May 2005 and started robotic 
surgery in July 2005. In June 2006, a new da Vinci S System (In-
tuitive Surgical) replaced the existing standard system. The sec-
ond and third da Vinci S systems (Intuitive Surgical) were in-
troduced in June 2006 and January 2008. In January 2010, the 
fourth da Vinci Si System (Intuitive Surgical) was introduced 
for a total of four robotic systems. Between July 2005 and De-
cember 2013, the robotic surgery system was used for a total 
of 10267 cases.
Although robotic surgery at Severance Hospital was started 
with only six surgeons from three different departments (gen-
eral surgery, urology, thoracic surgery) in 2005, more than 40 
surgeons from seven departments, including obstetrics and 
gynecology, otorhinolaryngology, cardiac surgery, and neuro-
surgery, perform robotic surgeries at present. A statistical 
analysis of the number of procedures performed by each sur-
geon revealed that 15 surgeons performed 93.47% of all 10000 
surgeries. One surgeon performed more than 2500 surgeries, 
two surgeons performed more than 1400 surgeries each, two 
surgeons performed more than 500 surgeries each, and 10 sur-
geons performed more than 100 surgeries each. 
The Minimal Invasive Surgery Center of the Severance Hos-
pital is in charge of all business affairs related to robotic sys-
tems and is responsible for gathering statistical and clinical 
data regarding robotic surgeries conducted at Severance Hos-
pital. 
Analysis of annual robotic surgeries at Severance 
Hospital 
Table 1 shows the annual reports of the numbers of robotic 
procedures. Fig. 1 shows the cumulative numbers per depart-
ment, per organ procedures, and in total for the period be-
tween 2005 and 2013 at Severance Hospital. Since robotic sur-
gery first began in 2005, there has been a constant increase in 
the number of procedures. The cumulative procedures per-
formed at a single center were 1000 and 5000 in 2008 and 2010, 
respectively. The cumulative number of da Vinci procedures 
reached 10000 in November 2013. The total annual number of 
procedures in 2008, when the third robotic system was intro-
duced, was 1000. The total annual numbers of procedures were 
1600 in 2009, 1700 in 2010, and 1800 in 2012. From 2009 to 
2013, more than 1500 procedures were performed each year.
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The department with the highest number of robotic proce-
dures was general surgery (54.9%), which is much higher than 
the numbers of other departments, such as urology (33.0%), 
otorhinolaryngology (7.0%), and obstetrics and gynecology 
(3.2%). The yearly analysis showed that urology had the high-
est number of procedures from 2005 to 2007. However, from 
2007 to 2008, general surgery procedures rapidly increased, 
and it had the highest number of procedures until 2013. Urolo-
gy procedures increased every year until 2009; after that time, 
the number has remained stable. The frequency of otorhino-
laryngology procedures rapidly increased after 2010. More-
over, the numbers of procedures performed in the obstetrics 
and gynecology department and other departments have de-
creased and have shown no signs of increasing.
Analysis of annual robotic surgery according to organ
Table 1 and Fig. 1B show the number of annual procedures ac-
cording to the operated organs. Most surgeries were performed 
for the thyroid (40.8%) and prostate (27.4%) glands; these two 
organs accounted for more than half of all procedures. Other 
prominent areas included the stomach (7.6%), colon and rec-
tum (7.5%), kidney (5.1%), head and neck (4.0%), uterus (3.2%), 
thorax (1.5%), and others (2.9%).
The results analyzed according to year revealed trends simi-
lar to those seen after the analysis performed according to de-
partment. Thyroid surgeries showed an increase similar to 
that seen for the annual trend in general surgery. Thyroid pro-
cedures were first performed at our hospital in 2007. Although 
they began slightly later than prostate surgeries, a drastic in-
crease was seen in 2008. From 2008 until 2013, thyroid proce-
dures comprised the majority of procedures. 92.7% of thyroid 
procedures are performed in the general surgery department; 
among all procedures in the general surgery department, thy-
roid procedures have the highest percentage (69.6%). Prostate 
procedures are only performed in the urology department 
(83.2%); therefore, the annual trend of prostate procedures is 
very similar to that of annual urology procedures. In contrast, 
procedures on the colon and rectum, stomach, kidney, head 
and neck, and uterus have remained constant, and no appar-
ent growth trend was observed. 
Analysis of robotic surgery for malignant and 
non-malignant disease 
We compared statistics related to robotic surgery for malig-
Table 1. Number of Robotic Procedures Using the da Vinci Surgical System (Intuitive Surgical) according to Department and Organs at Yonsei Univer-
sity Severance Hospital
2005 2006 2007 2008 2009 2010 2011 2012 2013 Total %
By department
GS 11 55 197 588 967 1053 820 990 960 5641 54.9
Endocrine 0 0 50 341 735 716 594 760 703 3899 38.0
Upper GI tract 8 43 74 97 96 134 80 113 142 787 7.7
Lower GI tract 0 10 66 120 115 174 122 87 74 770 7.5
HBP 3 2 7 28 21 26 7 9 19 122 1.2
Pediatric 0 0 0 2 0 3 17 21 22 65 0.6
URO 12 98 230 434 566 504 452 545 551 3392 33.0
OBGY 0 18 22 41 52 67 51 44 32 326 3.2
ENT 0 0 0 15 28 93 193 205 187 721 7.0
TS 1 7 18 10 2 11 26 33 41 149 1.5
CS 0 6 11 8 3 1 1 0 0 30 0.3
NS 0 0 0 0 1 4 1 1 0 7 0.1
Total 24 184 478 1096 1621 1733 1544 1818 1771 10267 100.0
By organ
Thyroid 0 0 50 338 731 752 696 846 771 4184 40.8
Prostate 11 96 207 350 448 408 393 444 459 2816 27.4
Stomach 8 43 74 97 96 134 80 113 139 784 7.6
Colorectal 0 10 67 121 115 175 122 87 73 770 7.5
Kidney/ureter 1 2 18 75 107 86 57 93 88 527 5.1
Head and neck 0 0 0 15 26 51 89 118 113 412 4.0
Uterus 0 18 22 41 52 67 51 44 34 329 3.2
Thoracic 1 7 18 10 2 11 26 33 41 149 1.5
Other 3 8 23 49 42 49 30 40 52 296 2.9
Total 24 184 479 1096 1619 1733 1544 1818 1770 10267 100.0
CS, cardiac surgery; GI, gastrointestinal; GS, general surgery; HBP, hepatobiliary; ENT, ear/nose/throat; NS, neurosurgery; OBGY, obstetrics and gynecology; TS, 
thoracic surgery; URO, urology.
978
Efficacy and Safety of Robotic Surgeries
https://doi.org/10.3349/ymj.2018.59.8.975
nant and non-malignant diseases (Fig. 2). Procedures for ma-
lignant disease comprised the majority (94.5%) of all robotic 
procedures. However, only 569 procedures were performed 
for non-malignant diseases. Of these, the proportion of thy-
roid surgeries was highest (144), followed by head and neck 
(117), uterus (67), pediatric (65), hepatobiliary (33), adrenal 
(32), heart (30), kidney/ureter (27), pancreas (18), thoracic 
(11), and other (25) surgeries. All cardiac, adrenal, spleen, neu-
rosurgery, and pediatric surgeries were performed for non-
malignant diseases. Although the number of surgeries was still 
very low, compared to those for malignant diseases, robotic 
surgeries for benign diseases are constantly increasing.
Reliability and safety of robotic surgery
Although robotic surgery has many advantages over other sur-
gical approaches, many studies have reported that mechani-
cal failure and malfunction can occur because of its complexi-
ties.16-19 According to previous reports, the rate of malfunction 
and mechanical failure of robotic systems at Severance Hos-
pital was approximately 2.4% from 2005 to 2008.18,19 However, 
among the 10267 procedures that we analyzed, mechanical 
failure was observed for only 1.8%. Most of these were related 
to instrumental problems; however, because this was easily 
solved by replacing the malfunctioning instrument, no cases of 
malfunction led to conversion to open or laparoscopic surgery 
(Table 2). There were only seven cases of malfunction of the 
Fig. 2. Number of robotic procedures according to organs (A) and cumulative number of procedures (B) for benign disease.
Fig. 1. Cumulative number and annual number of robotic procedures ac-
cording to departments (A) and organs (B) at the Severance Hospital.
Table 2. Mechanical Failure and Malfunction of Robotic Surgery Using the 
da Vinci Surgical System (Intuitive Surgical)
Type of mechanical failure and malfunction Cases (%)
Mechanical failure and malfunction 32 (17.3)
System error 23 (12.4)
Instrument error 130 (70.3)
Total 185 (100)
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robotic system that directly caused conversion to another ap-
proach: three cases were converted to laparoscopic surgery and 
four were converted to open surgery. After 2008, despite sig-
nificant increases in the number of procedures, the numbers 
of malfunctions and failures have not increased significantly. 
This is mostly because the da Vinci system (Intuitive Surgical) 
has improved, and the experience level of surgeons has in-
creased. Furthermore, because a total of four robotic systems 
are being used, a malfunctioning one can be replaced with 
another.19 
Robotic surgery-related mortality among 10267 cases was 
also evaluated. During the entire analysis period, only 12 cas-
es (0.12%) were reported (Table 3). 
DISCUSSION
Minimally invasive surgery and robotic surgery have developed 
considerably in the past two decades. Robotic surgery presents 
advantages similar to those of minimally invasive surgery, such 
as less postoperative pain, shorter hospital stay, quicker recov-
ery, and smaller wounds. In addition, robotic surgery allows a 
three-dimensional magnified view of the surgical field, en-
ables intuitive movements, eliminates hand tremors, and pro-
vides a larger range of motion, all of which provide significant 
advantages for surgeries performed in limited and confined 
spaces.20 These advantages are primarily observed for surgeries 
performed in the obstetrics and gynecology, urology, and gen-
eral surgery departments.
Although the majority of robotic surgeries have been per-
formed in the United States, their incidence is increasing in 
other countries, including Korea. According to the official sta-
tistical data provided by Intuitive Surgical in 2014, a total of 2965 
da Vinci Surgical Systems (Intuitive Surgical) are in use in 55 
countries, and 2083 systems are being used in the United States. 
In Asia, a total of 288 da Vinci Surgical Systems (Intuitive Sur-
gical) are in use across 10 countries, including 43 systems in 
Korea. Singapore has the highest proportion of robots per mil-
lion population (1.27/million population), followed by Japan 
(1.25/million population) and Korea (0.85/million popula-
tion).5,21-23 This indicates that robotic surgery has been rapidly 
increasing in Korea over the past 10 years.
According to data regarding annual worldwide procedures 
provided by Intuitive Surgical,5 gynecologic and urologic sur-
geries are rapidly increasing. Since 2006, gynecologic proce-
dures have been constantly increasing, thereby comprising 
more than half of all robotic surgeries performed in 2010. How-
ever, according to the Korean Central Cancer Registry, which 
recorded the annual percentage of malignant diseases from 
1999 to 2011, the incidence of thyroid cancer was 23.3%, that of 
prostate cancer was 13.8%, and that of colorectal cancer was 5.6% 
per 0.1 million population, which differ from global data.24 This 
implies a difference in the number of robotic surgeries at Sev-
erance Hospital and that reported by global statistics. There-
fore, further statistical analyses are needed to explain this.
Thyroidectomy comprises a large portion of robotic surger-
ies at Severance Hospital, contrary to the global trend. The first 
robot-assisted thyroidectomy was performed in 2007. The num-
bers rapidly increased within 1 year and are still increasing 
(Fig. 1B). Thyroidectomy is most frequently performed in the 
general surgery department at Severance Hospital. However, 
thyroidectomy is also performed in the otorhinolaryngology 
department, which also explains the constant increase in ro-
botic surgeries. Although urologic and gynecologic surgeries 
comprise the majority of robot-assisted procedures globally, 
thyroidectomy performed by the general surgery team is the 
most frequent robot-assisted surgery at Severance Hospital. Ac-
cording to the Korean Central Cancer Registry, the incidence 
rate of thyroid cancer per 0.1 million population increased by 
23.3% from 1999 to 2011.24 Endoscopic thyroidectomy was 
performed before robotic thyroidectomy, and it had limita-
tions of restricted vision, difficulty with instrument handling, 
and lack of tactile perception.25 More than 650 cases were per-
formed via endoscopic surgeries from 2001. Since 2007, when 
the robotic system was introduced, the number of robotic thy-
roidectomies has increased. Our institution was a pioneer of 
robotic thyroidectomy in Korea. On the basis of the develop-
ment and accumulated experience of many surgical methods, 
we extended the indication for the robotic system to more ad-
vanced cases.26,27 Current studies have reported surgical out-
comes comparable to those of conventional procedures.28,29 
 Robot-assisted prostatectomy was the first robot-assisted 
surgery performed in Korea. The proportion of cases thereof 
has constantly increased, and the increase is similar to global 
trends. Since the da Vinci surgical system was introduced at 
Severance Hospital, robot-assisted prostatectomy has been 
performed not only for localized prostate cancer but also for 
locally advanced prostate cancer.10,14,30-33 Among all prostatec-
tomy cases, 28% were performed for patients with locally ad-
vanced prostate cancer. Currently, active surveillance or focal 
therapy is recommended for patients with low-risk prostate 
cancer in Korea34,35; however, surgery is still the main treatment. 
In addition, robot-assisted prostatectomy is performed not 
only for high-risk patients but also for very high-risk patients 
Table 3. Number of Mortality Cases for Robotic Procedures Using the da Vinci Surgical System (Intuitive Surgical)
Year 2005 2006 2007 2008 2009 2010 2011 2012 2013 Total
Procedures (n) 24 184 479 1096 1619 1733 1544 1818 1770 10267
Robotic surgery-related mortality (n) 0 0 1 3 1 1 1 3 2 12
Mortality rate (%) 0.00 0.00 0.21 0.27 0.06 0.06 0.06 0.17 0.11 0.12
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with cancer stage beyond T3b or with bone metastasis; this 
trend is expected to persist at our institution.36,37 
 The proportion of gynecology cases in Korea is much lower 
than that seen globally. Although the number of cases of ro-
bot-assisted gynecologic procedures is constantly increasing, 
it is limited to malignancies, such as cervical cancer. Cervical 
cancer is the second most common malignancy in women 
globally, and regardless of geographical distribution, it is still a 
major cause of morbidity and mortality. However, the inci-
dence rate of cervical cancer in developing countries has been 
decreasing steadily over the past few decades due to early de-
tection, treatment, and vaccination.38,39 In Korea, the incidence 
of cervical cancer has been decreasing annually by 3.9% per 
0.1 million population.24 
 At our institution, compared to non-malignant diseases, 
most malignancies were treated with robotic surgery. Debates 
regarding surgical results and differences in treating benign 
diseases with the traditional laparoscopic approach and ro-
bot-assisted surgery still exist. Robotic surgery for benign dis-
ease is not covered by the private insurance system in Korea, 
which is an obstacle. However, indications for robotic surgery 
for non-malignant gynecologic conditions, such as uterine my-
oma, are increasing. Despite the lack of evidence and high costs, 
robot-assisted surgery for non-malignant conditions is increas-
ing because it provides several advantages in limited working 
fields, such as intracorporeal suturing, pediatric patients, pa-
tients with small pelvises, cardiac surgery, and head and neck 
surgery.40 Along with the accumulation of experience and im-
provement in cost-effectiveness, robotic surgery for non-ma-
lignant disease is expected to generate competition in the field 
of surgery. Therefore, the role of robotic surgery in the gyneco-
logic field is expected to grow. 
Robotic systems involve very complex instruments with mu-
tual organic unification. Malfunction or mechanical failure in 
the robotic system could lead to serious perioperative prob-
lems. The largest study to evaluate the malfunction risk when 
using robotic systems in general surgery reported a malfunc-
tion incidence of 3.4%, although the rate of conversion to open 
surgery was only 0.2%.41 Except for problems with instruments, 
the system failure rate was only 1.7%, and no mortality and 
morbidity related to robotic dysfunctions were reported. Ac-
cording to the United States Food and Drug Administration da-
tabase, only 168 cases of malfunction were reported for more 
than 50000 cases during 8 years of robotic surgery.42 Among 
1797 robotic surgery cases at our institution,18 malfunction 
was reported for 2.4% (43) cases; among these cases, 44.2% 
(19) were due to instrument error. In this study, the malfunc-
tion rate decreased to 1.7% since 2009; the overall malfunc-
tion rate was 1.8% among 10000 cases; and the rate of conver-
sion was very low. All cases involving malfunction and failure 
were handled intraoperatively without stopping the surgery. 
Robotic surgery-related mortality was defined as conversion 
to open surgery and death of the patient. Since 2005, there have 
been no deaths, and 0.12% (12) of cases required conversion 
to open surgery for reasons, such as major vessel injury (three 
cases) or severe adhesion (nine cases). Previously published 
studies have reported a 2% open/radical conversion rate for 
robotic partial nephrectomy and a 1.1% conversion rate for ro-
botic surgery for gynecology.43,44
The incidence of robotic procedures in Korea has grown 
dramatically in the past decade as the incidence of cancer con-
tinues to increase. Moreover, approximately 33% of all robotic 
systems in Asian countries are in Korea, which has the second-
highest number of robotic systems in a single Asian country.5,45
This study had several limitations. First, this was a retro-
spective review based on medical records. Second, this study 
was not a comparative study, and a descriptive analysis of 
data could not prove superiority to other methods. Finally, the 
data analysis at a single institution did not reflect or represent 
global trends. Despite these limitations, our study analyzed 
robotic surgery for 10000 cases of various diseases in seven 
different departments of a single institution.
In conclusion, at our institute, increases in the incidence of 
robotic surgeries were similar to worldwide trends. However, 
there were characteristic differences in the incidences of thy-
roid and obstetric surgeries between 2005 and 2013. Our ex-
perience, based on 10267 robotic surgeries performed at our 
hospital, indicates that the system has high reliability and a 
low incidence of malfunction, failure, and mortality. Therefore, 
robotic surgery can be considered a safe alternative to conven-
tional surgery. 
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